LLY

735.75

-1.52%↓

JNJ

154.08

+0.56%↑

ABBV

183.18

-0.33%↓

NVO

69.37

+1.64%↑

UNH

306.43

-4.54%↓

LLY

735.75

-1.52%↓

JNJ

154.08

+0.56%↑

ABBV

183.18

-0.33%↓

NVO

69.37

+1.64%↑

UNH

306.43

-4.54%↓

LLY

735.75

-1.52%↓

JNJ

154.08

+0.56%↑

ABBV

183.18

-0.33%↓

NVO

69.37

+1.64%↑

UNH

306.43

-4.54%↓

LLY

735.75

-1.52%↓

JNJ

154.08

+0.56%↑

ABBV

183.18

-0.33%↓

NVO

69.37

+1.64%↑

UNH

306.43

-4.54%↓

LLY

735.75

-1.52%↓

JNJ

154.08

+0.56%↑

ABBV

183.18

-0.33%↓

NVO

69.37

+1.64%↑

UNH

306.43

-4.54%↓

Search

Savara Inc

Open

SectorGezondheidszorg

2.99 -0.99

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

3.01

Max

3.17

Belangrijke statistieken

By Trading Economics

Inkomsten

2.4M

-27M

EPS

-0.12

Winstmarge

-10,677.941

Werknemers

59

EBITDA

2.7M

-28M

Aanbevelingen

By TipRanks

Aanbevelingen

Strong Buy

12 Maanden Prognose

+170.7% upside

Dividenden

By Dow Jones

Volgende Winsten

8 aug 2025

Marktinformatie

By TradingEconomics

Marktkapitalisatie

20M

541M

Vorige openingsprijs

3.98

Vorige sluitingsprijs

2.99

Nieuwssentiment

By Acuity

50%

50%

179 / 382 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Neutral Evidence

Savara Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

20 mei 2025, 20:54 UTC

Acquisities, Fusies, Overnames

PNC to Buy Private-Equity Agent Aqueduct Capital

20 mei 2025, 20:50 UTC

Winsten

Palo Alto Networks Posts Higher 3Q Sales, Profit Slips

20 mei 2025, 23:48 UTC

Acquisities, Fusies, Overnames

Kraft Heinz Evaluating Strategic Transactions, Berkshire Hathaway Steps Away From Board -- Update

20 mei 2025, 23:42 UTC

Marktinformatie

Nikkei May Trade Rangebound Amid Tariff Uncertainty -- Market Talk

20 mei 2025, 23:39 UTC

Marktinformatie

Gold Steady, Supported by Lingering U.S. Fiscal-Deficit Concerns -- Market Talk

20 mei 2025, 23:08 UTC

Marktinformatie

James Hardie's Repair & Remodel Outlook Surprises RBC -- Market Talk

20 mei 2025, 22:46 UTC

Acquisities, Fusies, Overnames

Gold Road: Takeover Remains Subject to Independent Expert Findings; Shareholder, Court Approval

20 mei 2025, 22:45 UTC

Acquisities, Fusies, Overnames

Gold Road: Notified Australia Government Has No Objections to Takeover by Gold Fields

20 mei 2025, 22:44 UTC

Top Nieuws

Venezuela Frees U.S. Air Force Veteran in Overture to Trump -- 2nd Update

20 mei 2025, 22:20 UTC

Top Nieuws

In Latest EV Pullback, Ford to Share Battery Plant With Nissan -- WSJ

20 mei 2025, 22:00 UTC

Winsten

ZTO Express (Cayman) 1Q Adj EPS 37c >ZTO

20 mei 2025, 22:00 UTC

Winsten

ZTO Express (Cayman) 1Q EPS 34c >ZTO

20 mei 2025, 22:00 UTC

Winsten

ZTO Express (Cayman) 1Q Rev $1.5B >ZTO

20 mei 2025, 21:44 UTC

Winsten

James Hardie Industries 4Q Adj EPS 36c >JHX

20 mei 2025, 21:44 UTC

Winsten

James Hardie Industries: Sees FY26 North America Net Sales Growth Up Low Single Digits >JHX

20 mei 2025, 21:44 UTC

Winsten

James Hardie Industries 4Q EPS 10c >JHX

20 mei 2025, 21:44 UTC

Winsten

James Hardie Industries 4Q Sales $972M >JHX

20 mei 2025, 20:52 UTC

Top Nieuws

Elon Musk to Cut Back Political Spending -- 3rd Update

20 mei 2025, 20:52 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

20 mei 2025, 20:52 UTC

Marktinformatie

Mexican Stocks Near Record High As Trade Concerns Ease -- Market Talk

20 mei 2025, 20:30 UTC

Acquisities, Fusies, Overnames

PNC Financial: Aqueduct Acquisition Expected to Close in Mid-Summer, Terms Won't be Disclosed >PNC

20 mei 2025, 20:28 UTC

Acquisities, Fusies, Overnames

PNC Bank Agrees To Acquire Aqueduct Capital Group To Complement Harris Williams Capabilities >PNC

20 mei 2025, 20:23 UTC

Acquisities, Fusies, Overnames

Tesla CEO Musk Says He Plans to Be at White House for a Couple Days Every Few Weeks

20 mei 2025, 20:22 UTC

Winsten

XP 1Q Adj EPS BRL2.29 >XP

20 mei 2025, 20:22 UTC

Winsten

XP 1Q Rev BRL4.345B >XP

20 mei 2025, 20:21 UTC

Acquisities, Fusies, Overnames

Tesla CEO Musk: 'We're in the Big Bang of Intelligence Explosion'

20 mei 2025, 20:20 UTC

Top Nieuws

Fed's Bostic Signals Longer Delay in Cutting Interest Rates -- Barrons.com

20 mei 2025, 20:19 UTC

Acquisities, Fusies, Overnames

Tesla CEO Musk Says He Doesn't Currently Have Plans to Merge Tesla, xAI

20 mei 2025, 20:11 UTC

Top Nieuws

Venezuela Frees U.S. Air Force Veteran in Overture to Trump -- Update

20 mei 2025, 20:09 UTC

Winsten

Palo Alto Networks 3Q Remaining Performance Obligation $13.5 B >PANW

Peer Vergelijking

Prijswijziging

Savara Inc Prognose

Koersdoel

By TipRanks

170.7% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 8.5 USD  170.7%

Hoogste 16 USD

Laagste 3 USD

Gebaseerd op 7 Wall Street-analisten die 12-maands prijsdoelen bieden voor Savara Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

7 ratings

6

Buy

1

Hold

0

Sell

Technische score

By Trading Central

2.76 / 2.84Steun & Weerstand

Korte Termijn

Neutral Evidence

Gemiddeld Termijn

Very Strong Bullish Evidence

Lange Termijn

Weak Bullish Evidence

Sentiment

By Acuity

179 / 382 Rangschikking in Gezondheidszorg

Nieuwssentiment

Neutral

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Boven gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Savara Inc

Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. The company's lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase 3 development stage for the treatment of autoimmune pulmonary alveolar proteinosis. Savara Inc. is headquartered in Langhorne, Pennsylvania.